Epstein Secrets

stice, Bureau of Prisons, Drug Abuse Treatment Program, 81 Fed. Reg. 24484, 24488 (Apr. 26, 2016) ("over 5,000 inmates waiting to enter treatment"); Colson Task Force, at 36 Cat the end of FY 2014, more than 12,300 people systemwide were awaiting drug abuse treatment'). 20 EFTA00100213 EXHIBIT B EFTA00100214

ine and in Attachment D. EFTA00100219 Kathleen Hawk Sawyer, Director Federal Bureau of Prisons October 14, 2019 Page 6 According to Oklahoma's Federal Public Defender, it is not financially feasible for the current reentry center to bid for this contract with expanded obligations but reduced guarantees. The contr

stice, Bureau of Prisons, Drug Abuse Treatment Program, 81 Fed. Reg. 24484, 24488 (Apr. 26, 2016) ("over 5,000 inmates waiting to enter treatment"); Colson Task Force, at 36 Cat the end of FY 2014, more than 12,300 people systemwide were awaiting drug abuse treatment'). 20 EFTA00064950 EXHIBIT B EFTA00064951

ine and in Attachment D. EFTA00064956 Kathleen Hawk Sawyer, Director Federal Bureau of Prisons October 14, 2019 Page 6 According to Oklahoma's Federal Public Defender, it is not financially feasible for the current reentry center to bid for this contract with expanded obligations but reduced guarantees. The contr

stice, Bureau of Prisons, Drug Abuse Treatment Program, 81 Fed. Reg. 24484, 24488 (Apr. 26, 2016) ("over 5,000 inmates waiting to enter treatment"); Colson Task Force, at 36 Cat the end of FY 2014, more than 12,300 people systemwide were awaiting drug abuse treatment'). 20 EFTA00094068 EXHIBIT B EFTA00094069

ine and in Attachment D. EFTA00094074 Kathleen Hawk Sawyer, Director Federal Bureau of Prisons October 14, 2019 Page 6 According to Oklahoma's Federal Public Defender, it is not financially feasible for the current reentry center to bid for this contract with expanded obligations but reduced guarantees. The contr